Site

Sophia Antipolis

The NUVISAN French R&D Hub

Our excellence center for Chemistry, Formulation development, Analytics, Clinical Trial Supplies and Bioanalysis.

Our motivated and experienced employees are highly skilled for the development and manufacture of topical products.

Infrastructure

Headcount: 90 employees, ex-pharma industry, 84% university graduates: 42% Bachelor degree & 42 % Master degree and PhD

Laboratories: 2.700 m²

Offices: 650 m²

Working Fields & Specialties

Chemistry: API synthesis, process development & GMP manufacturing

Topical Formulation : development of innovative formulation

GMP manufacturing of semi liquid formulations


Analytical services

Clinical Trial Supplies

Bioanalysis services

Quality Assurance & Regulatory Affairs services

Specialists in topical formulations for drugs and cosmetics

Inspections & Authorizations

GMP part I and II: 2019 and 2020


GLP compliant, certification planned in 2020

ISO 22716 compliant

French Research Tax Credit (CIR) accreditation

Index Egalité Femmes-Hommes

Total result 83/100.
83 points out of a maximum of 100.

History

GMP and GLP compliant site was established by GALDERMA in 2006 to become the largest R&D site of the world dedicated to dermatology.


NUVISAN acquired in Sept 2018 part of these R&D competencies and launched its operations in Oct 2018.